Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed &bgr;-Sheet Hypothesis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|30|3267-3279

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.30, 2008-10, pp. : 3267-3279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conformational Diseases: Structural Studies of Aggregation of Polyglutamine Proteins

By  

Current Computer - Aided Drug Design, Vol. 7, Iss. 1, 2011-03 ,pp. : 23-43

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation

By  

Current Pharmaceutical Design, Vol. 12, Iss. 20, 2006-07 ,pp. : 2543-2555

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting aggregation of extended polyglutamine proteins

By  

Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Transcriptional Dysregulation: A Therapeutic Target for Polyglutamine Diseases

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 2, 2005-06 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of Molecular Chaperones as a Therapeutic Strategy for the Polyglutamine Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 2, 2010-02 ,pp. : 188-197

Bentham Science Publishers

Access to resources Recommend Favorite